CDXS - Codexis Inc.

-

$undefined

N/A

(N/A)

Codexis Inc. NASDAQ:CDXS Codexis is a leading enzyme engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis' proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes.

Location: 421 SW 6th Ave Ste 700, Oregon, 97204-1618, US | Website: www.codexis.com | Industry: Paint and Coating Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

180M

Cash

73.2M

Avg Qtr Burn

-11.82M

Short % of Float

4.71%

Insider Ownership

2.35%

Institutional Own.

92.24%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date